Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 12:05 AM UTC
| NCT Number | NCT06520345 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE3 |
| Target Enrollment | 520 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Telix Pharmaceuticals (Innovations) Pty Limited |
| Last Updated on CT.gov | July 21, 2026 (Jul 21, 2026) |
As of October 18, 2026: Clinical trial NCT06520345 is currently recruiting participants. This phase3 study for prostate cancer is actively seeking new participants at 9 locations across the United States. The study is sponsored by Telix Pharmaceuticals (Innovations) Pty Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06520345 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06520345 was last updated Jul 21, 2026 (July 21, 2026). HelloStudys verifies this status automatically.